Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POCODEX: Pomalidomide, Cyclophosphamide and Dexamethasone in Refractory Multiple Myeloma
NCT04243109Phase 2Terminated
- Sponsor
- Maimónides Institute of Biomedical Research of Córdoba
- Start
- Feb 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in multiple myeloma (MM), sponsored by Maimónides Institute of Biomedical Research of Córdoba. Started Feb 2017; status: terminated.
02
Drugs
cyclophosphamide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04243109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04243109.